Aurobindo Pharma

quarterly
yearly
ParticularsJun '22Sep '22Dec '22Mar '23Jun '23
Revenue6,2365,7396,4076,4736,851
Expenses5,5515,2015,7745,8566,095
EBITDA685.23538.79633.01617.03755.06
EBIT405.72240.69311.61271.46428.50
Profit Before Tax678.99523.36680.11730.06812.03
Net Profit520.54409.45491.26506.27570.75
Financial Ratios
Operating Profit Margin10.99%9.39%9.88%9.53%11.02%
Net Profit Margin8.35%7.13%7.67%7.82%8.33%
Earning Per Share (Diluted)8.886.998.388.6410.58
Dividends Per ShareNANA3.00NANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ